We have opened a new subsidiary in Greece
Zurich, 13 May 2019 – VIO Chemicals, a science and technological innovation driven chemical company, announces that it has opened a new subsidiary in Greece, VIO Pharmaceuticals. The subsidiary will be responsible for marketing Active Pharmaceutical Ingredients and solely dedicated to serving end users and dealers in the pharmaceutical industry.
Pharmaceutical companies are continuously reviewing their needs in the face of social, economic and scientific challenges. “VIO Chemicals is uniquely placed to serve the global pharma industry as a mature company with a proven track record in chemical process design, development, production and sourcing of cost competitive, high quality and highly marketable products”, said Dimitris Kalias, VIO Chemicals CEO and founder. “By moving our global operations for the supply of APIs to Greece, we are able to cut down on significant administrative costs and offer even better business deals to our customers”, added Kalias.
Alongside the operation of its state-of-the-art R&D centre for APIs in Thessaloniki, VIO Chemicals taps into local talent and resources for a second time, supporting them and reinforcing a growing trend: Thessaloniki’s broader region is the new European destination hotspot for foreign investment. “Thessaloniki offers a unique entrepreneurship ecosystem that embodies innovation and incentivises sustainable competitiveness to access global markets”, added Dimitris Kalias.
The subsidiary is located at the Thermi Business Incubator’s facilities, Building Thermi 1, 47 Steliou Kazantzidi Str, GR 57001, Thessaloniki.
Besides its offices in Switzerland and Greece, the company has representation offices in China and India, and a broad network of sales agents, partners and suppliers in major European markets, as well as in Asia and the Americas.
Press contact: Maria Andrielou on +30 2310 477603 or at email@example.com